| Product NDC: | 61748-015 |
| Proprietary Name: | Rifampin |
| Non Proprietary Name: | Rifampin |
| Active Ingredient(s): | 150 mg/1 & nbsp; Rifampin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61748-015 |
| Labeler Name: | VersaPharm Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065028 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20010701 |
| Package NDC: | 61748-015-11 |
| Package Description: | 100 CAPSULE, COATED in 1 BOX, UNIT-DOSE (61748-015-11) |
| NDC Code | 61748-015-11 |
| Proprietary Name | Rifampin |
| Package Description | 100 CAPSULE, COATED in 1 BOX, UNIT-DOSE (61748-015-11) |
| Product NDC | 61748-015 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Rifampin |
| Dosage Form Name | CAPSULE, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20010701 |
| Marketing Category Name | ANDA |
| Labeler Name | VersaPharm Incorporated |
| Substance Name | RIFAMPIN |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |